Synapse

← Stephan Windecker

Papers by Stephan Windecker

Page 3 · newest first

  1. Bicuspid aortic valve disease: advancements and challenges of transcatheter aortic valve implantationEuropean Heart Journal · 2025
  2. Clinical Outcomes in Patients With Acute Pulmonary Embolism Undergoing Ultrasound‐Assisted Catheter‐Directed ThrombolysisSHILAP Revista de lepidopterología · 2025
  3. Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trialEuropean Heart Journal · 2025
  4. Appraisal of the 2024 revision of the level of evidence grading system in European Society of Cardiology GuidelinesEuropean Heart Journal · 2025
  5. Smoking Status at Baseline and 10-Year Outcomes After Drug-Eluting Stent ImplantationJACC: Cardiovascular Interventions · 2025
  6. Treatment of Mitral and Tricuspid Atrioventricular Valve Disease by Double Transcatheter Valve ReplacementJACC Case Reports · 2025
  7. Priorities for medical device regulatory approval: a report from the European Society of Cardiology Cardiovascular Round TableEuropean Heart Journal · 2025
  8. Tricuspid and mitral regurgitation after mitral transcatheter edge-to-edge repair: a complex interplayEuropean Heart Journal · 2025
  9. Simplified Outcome Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention by Survival Tree-Based ModellingJACC Advances · 2025
  10. Impact of coronary artery tortuosity on outcomes following stenting with newer-generation drug-eluting stents. An analysis of the randomized BIOFLOW trialsRevista Española de Cardiología (English Edition) · 2025
  11. Parsimonious versus extensive bleeding score: can we simplify risk stratification after percutaneous coronary intervention and reduce bleeding events by de-escalation of the antiplatelet strategy?Open Heart · 2025
  12. Hemodynamic Valve Deterioration After Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions · 2025
  13. Association between the intensity of statin therapy and physical activity 1 year after acute coronary syndrome: a multicentre prospective cohort study in SwitzerlandBMJ Open · 2025
  14. Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter ManagementCirculation · 2024
  15. Three‐Year Outcomes With a Supra‐Annular, Self‐Expanding Bioprosthesis and a Pericardial Wrap—The FORWARD PRO StudyCatheterization and Cardiovascular Interventions · 2024
  16. Flow Status-Based Predicted Prosthesis-Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement With a Balloon-Expandable ValveStructural Heart · 2024
  17. 5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled TrialJournal of the American College of Cardiology · 2024
  18. Timing of Aortic Valve Intervention in the Management of Aortic StenosisJACC: Cardiovascular Interventions · 2024
  19. Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS TrialCirculation Cardiovascular Interventions · 2024
  20. Association of Lipoprotein(a) With Changes in Coronary Atherosclerosis in Patients Treated With AlirocumabCirculation Cardiovascular Imaging · 2024
  21. Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary InterventionCirculation · 2024
  22. Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction: a target trial emulation from a real-world cohortEuropean Journal of Preventive Cardiology · 2024
  23. Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and MultimorbiditySHILAP Revista de lepidopterología · 2024
  24. Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary SyndromesJAMA Cardiology · 2024
  25. Ten‐year clinical outcomes after drug‐eluting stents implantation according to clinical presentation—Insights from the DECADE cooperationEuropean Journal of Clinical Investigation · 2024
  26. Multimodality Imaging in the Management of Tricuspid Valve RegurgitationEchocardiography · 2024
  27. Findings from transoesophageal echocardiographic follow-up after mitral transcatheter edge-to-edge repairEuroIntervention · 2024
  28. Multi-modality artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosisEuropean Journal of Nuclear Medicine and Molecular Imaging · 2024
  29. Risk Stratification in Nonischemic Dilated Cardiomyopathy Using CMR ImagingJAMA · 2024
  30. Incidence and predictors of continued ascending aortic dilatation after TAVI in patients with bicuspid aortic stenosisClinical Research in Cardiology · 2024
  31. Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromesAtherosclerosis Plus · 2024
  32. Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial InfarctionJAMA Cardiology · 2024
  33. Obesity and cardiovascular disease: an ESC clinical consensus statementEuropean Heart Journal · 2024
  34. Mitral regurgitation evolution after transcatheter tricuspid valve interventions—a sub-analysis of the TriValve registryEuropean Heart Journal - Cardiovascular Imaging · 2024
  35. Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II TrialEuropean Heart Journal · 2024
  36. Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve ReplacementJACC Advances · 2024
  37. Antithrombotic therapy for transcatheter structural heart interventionEuroIntervention · 2024
  38. Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Who Have Undergoing Transcatheter Aortic Valve ReplacementCanadian Journal of Cardiology · 2024
  39. Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary SyndromeCirculation · 2024
  40. Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectivesEuropean Heart Journal · 2024
  41. One-Month Dual Antiplatelet Therapy in High Bleeding Risk Asian Patients Undergoing Percutaneous Coronary Intervention ― Onyx ONE Clear 2-Year Results ―Circulation Reports · 2024
  42. Ultrasound-Assisted Catheter-Directed Thrombolysis Versus Surgical Pulmonary Embolectomy for Intermediate-High or High-Risk Pulmonary Embolism: A Randomized Phase II Non-inferiority TrialEuropean Journal of Cardio-Thoracic Surgery · 2024
  43. Edoxaban and/or colchicine for patients with coronavirus disease 2019 managed in the out-of-hospital setting (CONVINCE): a randomized clinical trialJournal of Cardiovascular Medicine · 2024
  44. Sex-Specific Differences in Upstream Cardiac Damage in Patients With Aortic Stenosis Undergoing TAVRJACC: Cardiovascular Interventions · 2024
  45. One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromesEuroIntervention · 2024
  46. Automatic assessment of atherosclerotic plaque features by intracoronary imaging: a scoping reviewFrontiers in Cardiovascular Medicine · 2024
  47. Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation studyEuropean Heart Journal - Digital Health · 2024
  48. Congestion patterns in severe tricuspid regurgitation and transcatheter treatment: Insights from a multicentre registryEuropean Journal of Heart Failure · 2024
  49. Risk Burden of Cancer in Patients Treated With Abbreviated Dual Antiplatelet Therapy After PCI: Analysis of Multicenter Controlled High-Bleeding Risk TrialsCirculation Cardiovascular Interventions · 2024
  50. Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary InterventionJAMA Cardiology · 2024